Clinical Trial Update: T790M Mutation on ctDNA in Patients With NSCLC After EGFR-TKI Failure

View source ↗

Summary

A completed clinical trial evaluated detection of EGFR T790M mutation in circulating tumor DNA from patients with non-small cell lung cancer after EGFR-TKI fail…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: First People's Hospital of Hangzhou | Conditions: Non-small Cell Lung Cancer Stage III, Non-Small-Cell Lung Cancer Metastatic | Status: COMPLETED | Results posted: 2016-08-08